Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gynecology

Free Subscription Articles published in Lancet Retrieve available abstracts of 176 articles: HTML format

Single Articles

July 2021
1. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
   Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
   Lancet. 2021;398 Suppl 1:S45.
   PubMed     Abstract available
   
   
   
2. ISBEIH M, Venkateswaran M, Abbas E, Abu-Khader K, et al
   Gestational age recorded at delivery versus estimations using antenatal care data from the Electronic Maternal and Child Health Registry in the West Bank: a comparative analysis.
   Lancet. 2021;398 Suppl 1:S31.
   PubMed     Abstract available
   
   
   
3. EL-QATRAWI KJ
   Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
   Lancet. 2021;398 Suppl 1:S26.
   PubMed     Abstract available
   
   
   
4. BOGALE B, Morkrid K, O'Donnell B, Ghanem B, et al
   Development of a targeted client communication intervention for pregnant and post-partum women: a descriptive study.
   Lancet. 2021;398 Suppl 1:S18.
   PubMed     Abstract available
   
   
   May 2021
5. CHAPPELL LC, Cluver CA, Kingdom J, Tong S, et al
   Pre-eclampsia.
   Lancet. 2021 May 27. pii: S0140-6736(20)32335.
   PubMed     Abstract available
   
   
   
6. MENON U, Gentry-Maharaj A, Burnell M, Singh N, et al
   Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
   Lancet. 2021 May 12. pii: S0140-6736(21)00731.
   PubMed     Abstract available
   
   
   
7. HURWITZ LM, Pinsky PF, Trabert B
   General population screening for ovarian cancer.
   Lancet. 2021 May 12. pii: S0140-6736(21)01061.
   PubMed    
   
   
   April 2021
8. THE LANCET
   Miscarriage: worldwide reform of care is needed.
   Lancet. 2021 Apr 26. pii: S0140-6736(21)00954.
   PubMed    
   
   
   
9. COOMARASAMY A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, et al
   Recurrent miscarriage: evidence to accelerate action.
   Lancet. 2021 Apr 23. pii: S0140-6736(21)00681.
   PubMed     Abstract available
   
   
   
10. COOMARASAMY A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, et al
    Sporadic miscarriage: evidence to provide effective care.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00683.
    PubMed     Abstract available
    
    
    
11. QUENBY S, Gallos ID, Dhillon-Smith RK, Podesek M, et al
    Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00682.
    PubMed     Abstract available
    
    
    
12. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    PubMed    
    
    
    
13. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    PubMed     Abstract available
    
    
    
14. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    PubMed    
    
    
    February 2021
15. TAYLOR HS, Kotlyar AM, Flores VA
    Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
    Lancet. 2021;397:839-852.
    PubMed     Abstract available
    
    
    January 2021
16. BOOTH A
    Honduras changes constitution to ban abortion.
    Lancet. 2021;397:360.
    PubMed    
    
    
    
17. LHEUREUX S, Cristea MC, Bruce JP, Garg S, et al
    Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2021;397:281-292.
    PubMed     Abstract available
    
    
    
18. BLAGDEN SP, Nicum S
    A source of hope for platinum-resistant ovarian cancer?
    Lancet. 2021;397:254-256.
    PubMed    
    
    
    
19. BOOTH A
    Argentina to legalise elective abortion.
    Lancet. 2021;397:82.
    PubMed    
    
    
    December 2020
20. CLARKE C
    Abortion and The Lancet's call to arms.
    Lancet. 2020;394:2241.
    PubMed    
    
    
    November 2020
21. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    PubMed    
    
    
    
22. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    PubMed     Abstract available
    
    
    
23. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    PubMed    
    
    
    September 2020
24. ALVES L
    Brazilian doctors condemn new rules on abortion.
    Lancet. 2020;396:808.
    PubMed    
    
    
    
25. SHAHAR-NISSAN K, Pardo J, Peled O, Krause I, et al
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;396:779-785.
    PubMed     Abstract available
    
    
    
26. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.
    PubMed    
    
    
    
27. EVANS DK, Acosta AM
    Lifting bans on pregnant girls in school.
    Lancet. 2020;396:667-668.
    PubMed    
    
    
    August 2020
28. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    PubMed    
    
    
    
29. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available
    
    
    
30. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    
    
    
    
31. VON DADELSZEN P, Bhutta ZA, Sharma S, Bone J, et al
    The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    Lancet. 2020;396:553-563.
    PubMed     Abstract available
    
    
    
32. POUCHOT J, Couprie A
    A wandering spleen, splenomegaly, hypersplenism, and iron deficiency anaemia.
    Lancet. 2020;396:412.
    PubMed    
    
    
    
33. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    PubMed    
    
    
    
34. MAEDA Y, Ogawa K, Kamihara Y, Tanimoto T, et al
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:308.
    PubMed    
    
    
    
35. CHAPPELL LC, Juszczak E, Shennan A
    Managing late preterm pre-eclampsia - Authors' reply.
    Lancet. 2020;396:308-309.
    PubMed    
    
    
    
36. CARBILLON L
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:307-308.
    PubMed    
    
    
    July 2020
37. JAFFE S
    US Supreme Court upholds abortion rights, for now.
    Lancet. 2020;396:85-86.
    PubMed    
    
    
    
38. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    PubMed    
    
    
    
39. MCGOVERN T
    US Global Gag Rule increases unsafe abortion.
    Lancet. 2020;396:24-25.
    PubMed    
    
    
    
40. GINSBURG O, Horton R
    A Lancet Commission on women and cancer.
    Lancet. 2020;396:11-13.
    PubMed    
    
    
    June 2020
41. ALLEN S, Cortina CS
    An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant.
    Lancet. 2020;395:1937.
    PubMed    
    
    
    
42. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    PubMed     Abstract available
    
    
    May 2020
43. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    PubMed    
    
    
    April 2020
44. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    PubMed    
    
    
    March 2020
45. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    PubMed     Abstract available
    
    
    
46. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    PubMed    
    
    
    
47. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    
    
    
    February 2020
48. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    PubMed    
    
    
    
49. THE LANCET
    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    PubMed    
    
    
    
50. THE LANCET
    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    PubMed    
    
    
    
51. TANIGUCHI Y, Nishikawa H, Maeda N, Terada Y, et al
    Breathlessness, pleural effusions, fibromas, and Meigs syndrome: look beyond the chest and don't delay!
    Lancet. 2020;395:e32.
    PubMed    
    
    
    
52. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    PubMed    
    
    
    
53. THE LANCET
    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    PubMed    
    
    
    
54. UZOIGWE CE
    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    PubMed    
    
    
    
55. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    PubMed    
    
    
    
56. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    PubMed    
    
    
    
57. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    PubMed    
    
    
    
58. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    PubMed    
    
    
    January 2020
59. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    PubMed     Abstract available
    
    
    
60. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    PubMed     Abstract available
    
    
    
61. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    PubMed    
    
    
    
62. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    PubMed     Abstract available
    
    
    
63. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    
    
    
    
64. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    
    
    
    November 2019
65. LYERLY AD
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    PubMed    
    
    
    
66. CLAMP AR, James EC, McNeish IA, Dean A, et al
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32259.
    PubMed     Abstract available
    
    
    
67. ESKANDER RN, Monk BJ
    Moving beyond cytotoxic drug dosing in ovarian cancer.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32948.
    PubMed    
    
    
    
68. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    PubMed    
    
    
    October 2019
69. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed    
    
    
    
70. MILLER D
    Hyaluronan-selected sperm should not be considered an add-on - Author's reply.
    Lancet. 2019;394:1320.
    PubMed    
    
    
    
71. PARMEGIANI L
    Hyaluronan-selected sperm should not be considered an add-on.
    Lancet. 2019;394:1319-1320.
    PubMed    
    
    
    September 2019
72. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    PubMed    
    
    
    
73. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    PubMed    
    
    
    
74. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    PubMed     Abstract available
    
    
    August 2019
75. KOTSOPOULOS J
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    PubMed    
    
    
    
76. 
    Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available
    
    
    
77. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    PubMed    
    
    
    
78. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Abstract available
    
    
    
79. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed    
    
    
    
80. LAWRIE TA
    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    PubMed    
    
    
    
81. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    PubMed    
    
    
    
82. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    PubMed    
    
    
    
83. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    PubMed    
    
    
    
84. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed    
    
    
    
85. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    PubMed     Abstract available
    
    
    
86. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Abstract available
    
    
    
87. MARSCHALL HU
    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    PubMed    
    
    
    July 2019
88. BURKI T
    Northern Ireland likely to legalise abortion.
    Lancet. 2019;394:290.
    PubMed    
    
    
    
89. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    PubMed    
    
    
    
90. CHATTERJEE P
    Hysterectomies in Beed district raise questions for India.
    Lancet. 2019;394:202.
    PubMed    
    
    
    June 2019
91. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed    
    
    
    
92. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Abstract available
    
    
    
93. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    PubMed    
    
    
    
94. 
    HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    PubMed     Abstract available
    
    
    May 2019
95. THE LANCET
    We must all support women in the fight for abortion.
    Lancet. 2019;393:2099.
    PubMed    
    
    
    
96. JAFFE S
    Legal battles over abortion heat up in the USA.
    Lancet. 2019;393:1923-1924.
    PubMed    
    
    
    
97. LI A
    Northern Ireland deadlock impedes abortion rights progress.
    Lancet. 2019;393:1794.
    PubMed    
    
    
    
98. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    PubMed    
    
    
    
99. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    
    
    
    
100. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
     Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
     Lancet. 2019 May 2. pii: S0140-6736(18)32817.
     PubMed     Abstract available
     
     
     April 2019
101. THE LANCET
     Progress on investigating stillbirths.
     Lancet. 2019;393:1386.
     PubMed    
     
     
     
102. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
     Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
     Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
     PubMed     Abstract available
     
     
     March 2019
103. THE LANCET
     Gestational diabetes in England: cause for concern.
     Lancet. 2019;393:1262.
     PubMed    
     
     
     
104. WEI D, Liu JY, Sun Y, Shi Y, et al
     Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
     Lancet. 2019;393:1310-1318.
     PubMed     Abstract available
     
     
     
105. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
     Epithelial ovarian cancer.
     Lancet. 2019;393:1240-1253.
     PubMed     Abstract available
     
     
     
106. WATSON K
     Abortion as a moral good.
     Lancet. 2019;393:1196-1197.
     PubMed    
     
     
     
107. LAUFER MK
     Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
     Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
     PubMed    
     
     
     
108. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
     Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
     Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
     PubMed     Abstract available
     
     
     
109. ZHAO F, Qiao Y
     Cervical cancer prevention in China: a key to cancer control.
     Lancet. 2019;393:969-970.
     PubMed    
     
     
     February 2019
110. KLEBANOFF MA
     Interpregnancy interval after stillbirth: modifiable, but does it matter?
     Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
     PubMed    
     
     
     
111. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
     Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
     Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
     PubMed     Abstract available
     
     
     
112. KIOKO PM, Meana PR
     Abortion in Argentina.
     Lancet. 2019;393:745.
     PubMed    
     
     
     
113. GARCIA G
     Abortion in Argentina.
     Lancet. 2019;393:744.
     PubMed    
     
     
     
114. UZOIGWE CE
     Abortion in Argentina.
     Lancet. 2019;393:744-745.
     PubMed    
     
     
     
115. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
     Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
     Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
     PubMed     Abstract available
     
     
     
116. PALMER KR, Xiaohua L, Mol BW
     Management of intrahepatic cholestasis in pregnancy.
     Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
     PubMed    
     
     
     
117. REPPING S
     Evidence-based medicine and infertility treatment.
     Lancet. 2019;393:380-382.
     PubMed    
     
     
     
118. MILLER D, Pavitt S, Sharma V, Forbes G, et al
     Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
     Lancet. 2019;393:416-422.
     PubMed     Abstract available
     
     
     January 2019
119. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
     Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
     Lancet. 2019;393:330-339.
     PubMed     Abstract available
     
     
     
120. BUJOLD E, Hyett J
     Calcium supplementation for prevention of pre-eclampsia.
     Lancet. 2019;393:298-300.
     PubMed    
     
     
     
121. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
     Cervical cancer.
     Lancet. 2019;393:169-182.
     PubMed     Abstract available
     
     
     
122. THE LANCET
     Cervical cancer: unequal progress.
     Lancet. 2019;393:104.
     PubMed    
     
     
     December 2018
123. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
     The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
     Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
     PubMed     Abstract available
     
     
     
124. DIAZ-GARCIA C, Pellicer A
     Uterus transplantation from a deceased donor.
     Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
     PubMed    
     
     
     
125. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
     Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
     Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
     PubMed     Abstract available
     
     
     November 2018
126. THE LANCET
     Addressing preventable stillbirth and brain injury.
     Lancet. 2018;392:2238.
     PubMed    
     
     
     October 2018
127. FARQUHAR C
     Unexplained infertility - Authors' reply.
     Lancet. 2018;392:1517.
     PubMed    
     
     
     
128. GLEICHER N, Kuhnir VA, Barad DH
     Unexplained infertility.
     Lancet. 2018;392:1516-1517.
     PubMed    
     
     
     
129. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
     Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
     Lancet. 2018;392:1413-1422.
     PubMed     Abstract available
     
     
     
130. ADAMSON PC, Klausner JD
     No benefit of chlamydia screening in primary care?
     Lancet. 2018;392:1381-1383.
     PubMed    
     
     
     
131. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
     Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
     Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
     PubMed     Abstract available
     
     
     
132. KLEBANOFF MA, Brotman RM
     Treatment of bacterial vaginosis to prevent preterm birth.
     Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
     PubMed    
     
     
     September 2018
133. TEMMERMAN M, Lawn JE
     Stillbirths count, but it is now time to count them all.
     Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
     PubMed    
     
     
     
134. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
     Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
     Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
     PubMed     Abstract available
     
     
     August 2018
135. GRESSLER LE, Titus-Glover D, Shaya FT
     Treatment modalities for pregnant women with opioid use disorder.
     Lancet. 2018;392:551.
     PubMed    
     
     
     
136. SEN A, Nashef L
     New regulations to cut valproate-exposed pregnancies.
     Lancet. 2018;392:458-460.
     PubMed    
     
     
     July 2018
137. GHOSN J, Taiwo B, Seedat S, Autran B, et al
     HIV.
     Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
     PubMed     Abstract available
     
     
     
138. THE LANCET
     Cervical cancer prevention in Thailand-a model of success.
     Lancet. 2018;392:2.
     PubMed    
     
     
     June 2018
139. LI A
     From Ireland to Northern Ireland: campaigns for abortion law.
     Lancet. 2018;391:2403-2404.
     PubMed    
     
     
     
140. BOOTH A
     Argentina votes on bill to legalise abortion up to 14 weeks.
     Lancet. 2018;391:e21-e22.
     PubMed    
     
     
     
141. THE LANCET
     Dolutegravir for HIV: a lesson in pregnancy safety research.
     Lancet. 2018;391:2296.
     PubMed    
     
     
     May 2018
142. HALLGARTEN L
     Abortion narratives: moving from statistics to stories.
     Lancet. 2018 May 8. pii: S0140-6736(18)31036.
     PubMed    
     
     
     
143. SPERBER A
     El Salvador's total ban on abortion risks women's health.
     Lancet. 2018;391:1758-1759.
     PubMed    
     
     
     April 2018
144. BARNETT R
     Syphilis.
     Lancet. 2018;391:1471.
     PubMed    
     
     
     March 2018
145. THE LANCET
     Diagnosis of heavy menstrual bleeding: a change in direction.
     Lancet. 2018;391:1122.
     PubMed    
     
     
     
146. THE LANCET
     Abortion: access and safety worldwide.
     Lancet. 2018;391:1121.
     PubMed    
     
     
     
147. WATTS G
     New York Challenge sets high bar for HPV vaccination.
     Lancet. 2018;391:1137.
     PubMed    
     
     
     February 2018
148. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
     Management of pregnancy loss in the first trimester: a retrospective audit.
     Lancet. 2018;391 Suppl 2:S34.
     PubMed     Abstract available
     
     
     
149. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
     Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
     Lancet. 2018;391 Suppl 2:S26.
     PubMed     Abstract available
     
     
     
150. KATEEB E, Momany E
     Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
     Lancet. 2018;391 Suppl 2:S11.
     PubMed     Abstract available
     
     
     
151. LARSON HJ
     A global girl gang.
     Lancet. 2018;391:527-528.
     PubMed    
     
     
     
152. DEVI S
     FGM in Sierra Leone.
     Lancet. 2018;391:415.
     PubMed    
     
     
     December 2017
153. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
     Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
     Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
     PubMed     Abstract available
     
     
     
154. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
     Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
     Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
     PubMed     Abstract available
     
     
     
155. KVASKOFF M, Horne AW, Missmer SA
     Informing women with endometriosis about ovarian cancer risk.
     Lancet. 2017;390:2433-2434.
     PubMed    
     
     
     November 2017
156. GHORANI E, Kaur B, Fisher RA, Short D, et al
     Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
     Lancet. 2017;390:2343-2345.
     PubMed    
     
     
     
157. NANDI A, El-Toukhy T
     Stimulated intrauterine insemination for unexplained subfertility.
     Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
     PubMed    
     
     
     
158. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
     Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
     Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
     PubMed     Abstract available
     
     
     
159. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
     Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
     Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
     PubMed     Abstract available
     
     
     
160. MABEY D, Marks M, Peeling R, Lawn J, et al
     Stillbirth caused by syphilis remains a major global health problem.
     Lancet. 2017;390:2036.
     PubMed    
     
     
     
161. HEININGER U
     Syphilis in children.
     Lancet. 2017;390:2035-2036.
     PubMed    
     
     
     October 2017
162. REGAN L, Glasier A
     The British 1967 Abortion Act-still fit for purpose?
     Lancet. 2017;390:1936-1937.
     PubMed    
     
     
     
163. YIN Y
     HPV vaccination in China needs to be more cost-effective.
     Lancet. 2017;390:1735-1736.
     PubMed    
     
     
     September 2017
164. CASASSUS B
     Contraception implant removed from global market.
     Lancet. 2017;390:1576.
     PubMed    
     
     
     
165. GEMZELL-DANIELSSON K, Cleeve A
     Estimating abortion safety: advancements and challenges.
     Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
     PubMed    
     
     
     
166. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
     Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
     Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
     PubMed     Abstract available
     
     
     
167. GARG SK, Polsky S
     Continuous glucose monitoring in pregnant women with type 1 diabetes.
     Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
     PubMed    
     
     
     
168. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
     Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
     Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
     PubMed     Abstract available
     
     
     
169. DIZON DS
     PARP inhibitors for targeted treatment in ovarian cancer.
     Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
     PubMed    
     
     
     
170. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
     Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
     Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
     PubMed     Abstract available
     
     
     
171. DENNY L
     Nine-valent human papillomavirus vaccine: great science, but will it save lives?
     Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
     PubMed    
     
     
     
172. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
     Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
     Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
     PubMed     Abstract available
     
     
     July 2017
173. BANERJEE S
     Bevacizumab in cervical cancer: a step forward for survival.
     Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
     PubMed    
     
     
     
174. TEWARI KS, Sill MW, Penson RT, Huang H, et al
     Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
     Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
     PubMed     Abstract available
     
     
     April 2017
175. THE LANCET
     Syphilis: an ancient disease in a modern era.
     Lancet. 2017;389:1492.
     PubMed    
     
     
     December 2016
176. HOOK EW RD
     Syphilis.
     Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: